Work

A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.3050

Institutions: Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, Albert Einstein College of Medicine, Jacobi Medical Center, State Key Laboratory of Biotherapy

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891752425

Cites:

Cited by: 32

Related to: 10